Affiliation:
1. Mathabhanga SDH. WB.
2. Gangarampur SDH & SSH, WB
3. IPGMER And SSKM Hospital, Kolkata.
Abstract
Background: Misoprostol is a widely popularly used drug in treatment of missed abortions. It is very simple to use, easily available and has an
average efciency greater than 90%. Adrug this popular and versatile needs better study to improve its efciency and minimize all possible adverse
unwanted effects. Hence the idea to make a comparative study between the different modes of administration of Misoprostol was arrived upon so as
to understand it in a much better way. Aim: A comparison of the efcacy of Misoprostol used in sublingual, oral and vaginal routes for missed
abortion. Material and methods: The study was conducted at the Department of Obstetrics and Gynaecology in Nilratan Sircar Medical College
and Hospital, Kolkata after approval by the ethical committee. The sample size was 100 women being treated for missed abortions where
prospective sampling was carried out to determine the candidates to be selected for the study. Single centred, institution based, randomized
controlled trial. Cases included in this study were divided into 3 groups: Sublingual Group, Oral Group and Vaginal Group. Result: It was found
that in oral, 4(11.8%) patients had fever. In sublingual, 6(17.6%) patients had fever. In vaginal, 2(5.9%) patients had fever. Association of fever vs.
group was not statistically signicant (p=0.3220). Conclusion: The study demonstrates that both vaginal and sublingual misoprostol have similar
and higher success rates in inducing abortion compared to oral route
Reference11 articles.
1. Cunningham FG, Halvorson, Lisa M. First trimester abortion. In: Hoffman BL, Schorge JO, Bradshaw KD (editors). Williams Gynaecology 2nd ed, New York, NY: Mc Graw - Hill Companies; 2012:170-97.
2. Dhillon BS, Chandhiok N, Kambo I, Saxena NC. Induced abortion and concurrent adoption of contraception in rural areas of India. Ind J Med Sci. 2004;58(11):478-84.
3. Say L, Chou D, Gemmill A, Moller AB. Global causes of maternal death: a WHO systematic analysis. Lancet Glob Health. 2014;2(6):e323-33.
4. Drey EA, Foster DG, Jackson RA, Lee SJ, Cardenas LH, Darney PD, et al. Risk factors associated with presenting for abortions in second trimester. ObstetGynaecol. 2006;107(1):128-35.
5. Ngai SW, Chand YM, Tang O, Ho PC. Vaginal misoprostol as medical treatment for first trimester spontaneous miscarriage. Hum Reprod. 2001;16(7):1493-6.